Search all content on GOV.UK

Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with semaglutide in the treatment of type 2 diabetes, weight management...

• Updated: 5 February 2026

You may need to tell DVLA if you have a medical condition affecting one or both eyes - report it online or download a form to let them know

• If you have a car or motorcycle licence

  You can be fined up to £1,000 if you do not tell DVLA about a medical…

• If you have a bus, coach or lorry licence

  You can be fined up to £1,000 if you do not tell DVLA about a medical…

An overview of the NHS diabetic eye screening (DES) programme, its services and contact information.

• Updated: 8 July 2024

How to spot equine viral arteritis, what to do if you suspect it and measures to prevent its spread.

• Updated: 15 August 2019

MHRA updates product information regarding the very rare risk of non-arteritic anterior ischemic optic neuropathy (NAION) in patients taking semaglutide.

• Updated: 5 February 2026

These publications explain diabetic retinopathy and support the NHS diabetic eye screening (DES) programme.

• Updated: 16 September 2021

Guidance for the NHS diabetic eye screening (DES) programme.

• Updated: 22 June 2023

The vision profile presents indicators on sight loss outcomes, screening, risk factors and hospital activity for eye health.

• Updated: 1 July 2025

Population screening programmes: NHS diabetic eye screening (DES) programme

• Updated: 1 November 2023

Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of one batch of Ocumont Eye Ointment 1% w/w (POM). It was identified that the Braille information was inadvertently omitted during the approval...

• Updated: 27 January 2026